Cancer Vaccines Market Promising long-term growth outlook 2016-21
Asia-Pacific Cancer Vaccines Market by Treatment type, by Cancer Type, by Vaccine Type, by End User and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (20162021)
(EMAILWIRE.COM, December 28, 2017 ) According to the report Cancer Vaccines Market, published by Market Data Forecast, the Asia-Pacific market is projected to reach USD 1.05 billion by 2021, at a CAGR of 18.3% from 2016 to 2021.
A cancer vaccine is a vaccine that either treats existing cancer or avoids advancement of cancer. Vaccines that treat existing cancer are known as therapeutic cancer vaccines. A number of the vaccines are "autologous", being made from tests taken from the patient, and are particular to that patient. A few analysts guarantee that cancerous cells routinely emerge and are pulverized by the immune system and that tumors form when the immune system neglects to kill them.
A few sorts of cancer, for example, cervical cancer and some liver cancers, are caused by infections (oncoviruses). Customary vaccines against those infections, for example, HPV vaccine and hepatitis B vaccine, prevent those sorts of cancer. Different cancers are to some degree caused by bacterial infection(e.g. stomach cancer and Helicobacter pylori).
One way to deal with cancer vaccination is to isolate proteins from cancer cells and vaccinate patients against those proteins as antigens, in the expectation of fortifying the immune system to slaughter the cancer cells. Research on cancer vaccines is in progress for the treatment of breast, lung, colon, skin, kidney, prostate and different cancers.
Another approach is to produce an immune reaction in situ in the patient utilizing oncolytic viruses. This approach was utilized as a part of the medication talimogene laherparepvec, a variant of herpes simplex infection built to specifically duplicate in tumor tissue and to express the resistant stimulatory protein GM-CSF. This upgrades the anti-tumor safe reaction to tumor antigens discharged after viral lysis and gives a patient-specific vaccine.
Get a comprehensive overview of the Cancer Vaccines Market: http://www.marketdataforecast.com/market-reports/asia-pacific-cancer-vaccines-market-1422/
Cancer Vaccines Market: Drivers & Restraints
Asia-Pacific cancer vaccines market has driving factors like increasing number of people diagnosed with cancer, people getting aware of vaccines, smoking and excessive intake of alcohol, strong late-stage pipeline vaccines, vendors patient-assistance programs. Stringent regulations for getting approval, cost of vaccines are a few factors restraining the growth of this market.
Get accurate market forecast and analysis on the Cancer Vaccines Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/asia-pacific-cancer-vaccines-market-1422/request-sample
Cancer Vaccines Market: Segmentation
By Cancer Type
Prostate
Cervical
Anal
Throat
Other Cancers
By Vaccine Type
Protein and Peptide based
Tumour cell
Dendritic cell
Genetic vaccines
Other Vaccines
By End Users
Cancer Treatment Centres
Research Institutes
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/north-america-food-safety-testing-market-758/customize-report
Cancer Vaccines Market: Overview
Cancer vaccines are one of the progressive advancements that could reduc the torments and sufferings of cancer. The cancer vaccines have changed to a considerable measure the thought and philosophy of treating malignancy. It is the blend of new proteins from tumor regions blended with immune cells, which can detect and bind to the tumors effectively and with specificity. It is additionally getting such a great amount of attention because of its characteristic properties, for example, low toxicity, fewer symptoms, and high specificity.
Cancer Vaccines Market: Region-wise Outlook
North America is the top marketplace for Cancer Vaccines because of number of patients. Western Europe is observed as the growing market with the increase in the number of patients than Eastern Europe. The amount of prescribed thyroid hormone used in England only is more than double over the last ten years. More than the developed countries, the developing countries like Asia-Pacific, China, Japan, Middle East and Africa will likely to show tremendous growth in the market in the future due to high prevalence of iodine deficiency, increasing cases of goitre, the inability of in-depth diagnostic work-up, decrease diet and other factors.
Key Questions Answered
What is the current and future Cancer Vaccines systems market outlook in Asia-Pacific? What trends are affecting the Asia-Pacific market?
What is the competitive landscape and market share of major players in the Cancer Vaccines space in Asia-Pacific?
What are the key, high growth markets that Cancer Vaccines manufacturers should expand into? Which market segments are growing the fastest?
What are the unmet needs with the Cancer systems currently on the market? How will emerging technologies fulfil these unmet needs?
What is physician perception and market outlook of Cancer Vaccines?
What are the challenges and barriers that have hindered widespread adoption of Cancer Vaccines?
Cancer Vaccines Market: Key Players
Major players influencing the Asia-Pacific cancer vaccines market are Dendreon, GlaxoSmithKline and Merck. Companies with their products in pipeline are Aduro Biotech, Advantagene, Advaxis, Agenus, Altor BioScience, Argos Therapeutics, AVAX Technologies, Bavarian Nordic, Biothera, Celldex Therapeutics, CureVac, Galena Biopharma, Genexine, GlobeImmune, Gradalis, Heat Biologics, Immatics, ImmunoCellular Therapeutics, Inovio Pharmaceuticals, ISA Pharmaceuticals, Juvaris Biotherapeutics, NewLink Genetics, Northwest Biotherapeutics, NovaRx, OncoThyreon, Oncovir, Oxford BioMedica, Prima BioMed, Sotio, Transgene, Ubivac, Vaccinogen and Vaxon Biotech.
Reasons to buy Cancer Vaccines Market Report:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
A cancer vaccine is a vaccine that either treats existing cancer or avoids advancement of cancer. Vaccines that treat existing cancer are known as therapeutic cancer vaccines. A number of the vaccines are "autologous", being made from tests taken from the patient, and are particular to that patient. A few analysts guarantee that cancerous cells routinely emerge and are pulverized by the immune system and that tumors form when the immune system neglects to kill them.
A few sorts of cancer, for example, cervical cancer and some liver cancers, are caused by infections (oncoviruses). Customary vaccines against those infections, for example, HPV vaccine and hepatitis B vaccine, prevent those sorts of cancer. Different cancers are to some degree caused by bacterial infection(e.g. stomach cancer and Helicobacter pylori).
One way to deal with cancer vaccination is to isolate proteins from cancer cells and vaccinate patients against those proteins as antigens, in the expectation of fortifying the immune system to slaughter the cancer cells. Research on cancer vaccines is in progress for the treatment of breast, lung, colon, skin, kidney, prostate and different cancers.
Another approach is to produce an immune reaction in situ in the patient utilizing oncolytic viruses. This approach was utilized as a part of the medication talimogene laherparepvec, a variant of herpes simplex infection built to specifically duplicate in tumor tissue and to express the resistant stimulatory protein GM-CSF. This upgrades the anti-tumor safe reaction to tumor antigens discharged after viral lysis and gives a patient-specific vaccine.
Get a comprehensive overview of the Cancer Vaccines Market: http://www.marketdataforecast.com/market-reports/asia-pacific-cancer-vaccines-market-1422/
Cancer Vaccines Market: Drivers & Restraints
Asia-Pacific cancer vaccines market has driving factors like increasing number of people diagnosed with cancer, people getting aware of vaccines, smoking and excessive intake of alcohol, strong late-stage pipeline vaccines, vendors patient-assistance programs. Stringent regulations for getting approval, cost of vaccines are a few factors restraining the growth of this market.
Get accurate market forecast and analysis on the Cancer Vaccines Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/asia-pacific-cancer-vaccines-market-1422/request-sample
Cancer Vaccines Market: Segmentation
By Cancer Type
Prostate
Cervical
Anal
Throat
Other Cancers
By Vaccine Type
Protein and Peptide based
Tumour cell
Dendritic cell
Genetic vaccines
Other Vaccines
By End Users
Cancer Treatment Centres
Research Institutes
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/north-america-food-safety-testing-market-758/customize-report
Cancer Vaccines Market: Overview
Cancer vaccines are one of the progressive advancements that could reduc the torments and sufferings of cancer. The cancer vaccines have changed to a considerable measure the thought and philosophy of treating malignancy. It is the blend of new proteins from tumor regions blended with immune cells, which can detect and bind to the tumors effectively and with specificity. It is additionally getting such a great amount of attention because of its characteristic properties, for example, low toxicity, fewer symptoms, and high specificity.
Cancer Vaccines Market: Region-wise Outlook
North America is the top marketplace for Cancer Vaccines because of number of patients. Western Europe is observed as the growing market with the increase in the number of patients than Eastern Europe. The amount of prescribed thyroid hormone used in England only is more than double over the last ten years. More than the developed countries, the developing countries like Asia-Pacific, China, Japan, Middle East and Africa will likely to show tremendous growth in the market in the future due to high prevalence of iodine deficiency, increasing cases of goitre, the inability of in-depth diagnostic work-up, decrease diet and other factors.
Key Questions Answered
What is the current and future Cancer Vaccines systems market outlook in Asia-Pacific? What trends are affecting the Asia-Pacific market?
What is the competitive landscape and market share of major players in the Cancer Vaccines space in Asia-Pacific?
What are the key, high growth markets that Cancer Vaccines manufacturers should expand into? Which market segments are growing the fastest?
What are the unmet needs with the Cancer systems currently on the market? How will emerging technologies fulfil these unmet needs?
What is physician perception and market outlook of Cancer Vaccines?
What are the challenges and barriers that have hindered widespread adoption of Cancer Vaccines?
Cancer Vaccines Market: Key Players
Major players influencing the Asia-Pacific cancer vaccines market are Dendreon, GlaxoSmithKline and Merck. Companies with their products in pipeline are Aduro Biotech, Advantagene, Advaxis, Agenus, Altor BioScience, Argos Therapeutics, AVAX Technologies, Bavarian Nordic, Biothera, Celldex Therapeutics, CureVac, Galena Biopharma, Genexine, GlobeImmune, Gradalis, Heat Biologics, Immatics, ImmunoCellular Therapeutics, Inovio Pharmaceuticals, ISA Pharmaceuticals, Juvaris Biotherapeutics, NewLink Genetics, Northwest Biotherapeutics, NovaRx, OncoThyreon, Oncovir, Oxford BioMedica, Prima BioMed, Sotio, Transgene, Ubivac, Vaccinogen and Vaxon Biotech.
Reasons to buy Cancer Vaccines Market Report:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results